(Q45722674)

15 December 2017

title

Surface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavir (English)

1 reference

15 December 2017

0 references

1 reference

1 reference

1 reference

Sanyog Jain

1

1 reference

15 December 2017

Jagadish M Sharma

series ordinal

2

1 reference

15 December 2017

Amit K Jain

series ordinal

3

1 reference

15 December 2017

Rahul R Mahajan

series ordinal

4

1 reference

15 December 2017

publication date

25 January 2013

1 reference

15 December 2017

1 reference

15 December 2017

volume

8

1 reference

15 December 2017

issue

10

1 reference

15 December 2017

page(s)

1639-1655

1 reference

Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Novel targets for anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Nanomedicine--challenge and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Nanonization strategies for poorly water-soluble drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Controlling drug nanoparticle formation by rapid precipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Lutein nanocrystals as antioxidant formulation for oral and dermal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

A screening study of surface stabilization during the production of drug nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.181

21 January 2018

Identifiers

DOI

10.2217/NNM.12.181

1 reference

15 December 2017

1 reference